2015 was a crazy year for the Biotech industry, probably the craziest since the birth of the industry 40 years ago. I looked back on this year and here’s my personal top 3 of EU Biotechs which over-performed. I sorted them out in top partnerships, clinical trials and fundraising.
(Of course, this lists is not exhaustive and is not aimed to be so)
Top Partnerships – M&A deals
Galapagos + Gilead – Abbvie
Galapagos is a billion-euro Biotech from Belgium which had a big partnership with Abbvie. The american Biotech decided not to exercise its options, leaving Galapagos no other choice than finding a new partner. And just before the end of year, Galapagos announced it signed a €2Bn deal with Gilead, the extremely successful Californian Biotech. That’s massive!
Top Clinical Trials Results
Cellectis’ Miracle Saving of a 11-month Baby Girl
CAR-T was the big deal of 2015.